BEHAVIORAL · Unmapped registry intervention
Active social engagement group
Find medicine records ·
Find other trials using this name
Clinical trial
Conversations as a Means to Delay the Onset of Alzheimer's Disease
NCT01571427
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Control group
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedConversations as a Means to Delay the Onset of Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Mild Cognitive Impairmentunresolved
Cognitive Changeunresolved
Interventions
Active social engagement groupBEHAVIORAL
Control groupBEHAVIORAL
Sponsors & collaborators
Oregon Health and Science Universitylead sponsor
National Institute on Aging (NIA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01571427 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.